AbbVie (ABBV) operating cash flow was $19.0B in FY2025 (+1% YoY). The tables below show the complete quarterly and annual operating cash flow history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual Operating Cash Flow
Fiscal Year
Operating Cash Flow
YoY
2025
$19.0B
+1%
2024
$18.8B
-18%
2023
$22.8B
-8%
2022
$24.9B
+10%
2021
$22.8B
+30%
2020
$17.6B
+32%
2019
$13.3B
-1%
2018
$13.4B
+35%
2017
$10.0B
+41%
2016
$7.0B
-7%
2015
$7.5B
+112%
2014
$3.5B
-43%
2013
$6.3B
-1%
2012
$6.3B
+2%
2011
$6.2B
Recent Quarterly Operating Cash Flow
Quarter
Operating Cash Flow
Q2 2026
$3.4B
Q1 2026
$3.8B
Q4 2025
$5.2B
Q3 2025
$7.0B
Q2 2025
$5.2B
Q1 2025
$1.6B
Q4 2024
$7.0B
Q3 2024
$5.4B
Q2 2024
$2.3B
Q1 2024
$4.0B
Q4 2023
$4.8B
Q3 2023
$7.6B
Source: ABBV on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.